Put Options

21 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $4 Million - $4.86 Million
24,400 Added 25.52%
120,000 $23.7 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $27.5 Million - $32.1 Million
-177,400 Reduced 64.98%
95,600 $16.4 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $42.1 Million - $48 Million
263,600 Added 2804.26%
273,000 $49.7 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $2.12 Million - $2.39 Million
-15,400 Reduced 62.1%
9,400 $1.46 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $3.1 Million - $3.86 Million
23,400 Added 1671.43%
24,800 $3.34 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $5.68 Million - $6.55 Million
-39,300 Reduced 96.56%
1,400 $223,000
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $4.45 Million - $5.34 Million
32,200 Added 378.82%
40,700 $6.58 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $1.19 Million - $1.37 Million
-8,900 Reduced 51.15%
8,500 $1.14 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $7.61 Million - $9.68 Million
-55,300 Reduced 76.07%
17,400 $2.67 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $3.06 Million - $3.8 Million
-23,200 Reduced 24.19%
72,700 $11.8 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $225,603 - $285,453
-2,100 Reduced 2.14%
95,900 $13 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $31,920 - $36,234
300 Added 0.31%
98,000 $10.6 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $4.03 Million - $4.49 Million
-38,300 Reduced 28.16%
97,700 $11 Million
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $2.56 Million - $2.82 Million
-25,000 Reduced 15.53%
136,000 $14.7 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $12.8 Million - $17.2 Million
158,500 Added 6340.0%
161,000 $17.3 Million
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $17,182 - $20,166
200 Added 8.7%
2,500 $219,000
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $36,685 - $49,090
-500 Reduced 17.86%
2,300 $226,000
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $923,264 - $1.16 Million
-12,800 Reduced 82.05%
2,800 $248,000
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $711,674 - $855,636
11,300 Added 262.79%
15,600 $1.18 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $13,140 - $16,796
200 Added 4.88%
4,300 $313,000
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $316,274 - $372,239
4,100 New
4,100 $330,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.